GW842470X

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GW842470X, covering 2012-06-04 to 2012-06-04. Get the full timeline:

Most recent: Clinical Trial Update: Topical GW842470X In Adults Patients With Moderate Atopic Dermatitis [Phase 2]